Eating foods with plant sterols—like fortified margarine or nuts—helps lower your 'bad' cholesterol because they block your gut from absorbing too much cholesterol, so your liver makes more receptors...
Claim Context
Dietary phytosterols reduce circulating LDL cholesterol by inhibiting intestinal cholesterol absorption, prompting hepatic upregulation of LDL receptor activity to maintain cholesterol homeostasis.
“phytosteriles look almost identical to cholesterol. And when you eat them, they compete with cholesterol for absorption in your intestines, which means less cholesterol can make it through and get absorbed. But that's not where the magic happens. Because when it comes to cholesterol in our blood, most of it does not come from cholesterol that we eat. It's the cholesterol that's produced internally by our liver. So how this whole process works is the liver senses a drop in absorbed cholesterol. And because your liver tries to maintain its own cholesterol balance and homeostasis, it starts pulling more LDL particles out of the bloodstream.”
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
Evidence from Studies
Supporting (2)
Community contributions welcome
Use of phytosterol-fortified foods to improve LDL cholesterol levels: A systematic review and meta-analysis.
Liposomal Phytosterols as LDL-Cholesterol-Lowering Agents in Diet-Induced Hyperlipidemia.
Contradicting (0)
Community contributions welcome
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Direct causal effect of phytosterol intake on LDL cholesterol and hepatic LDL receptor activity in humans
In healthy adults with elevated LDL (n=80), randomly assign to daily intake of 2g phytosterols (in spread form) or placebo (matched texture/taste) for 6 weeks. Measure fasting LDL-C via ultracentrifugation, hepatic LDL receptor expression via liver biopsy (in a subset of 20 with clinical indication), and fecal sterol excretion via isotope-labeled cholesterol tracer. Control for diet, statin use, and genetic variants (e.g., ABCG5/G8). Primary outcome: % change in LDL-C; secondary: hepatic LDLR mRNA/protein levels and fractional cholesterol absorption rate.
Quantitative impact of phytosterols on cholesterol absorption and hepatic LDL clearance rates
In 30 normocholesterolemic adults, administer oral [13C]-cholesterol and [2H]-sitosterol (phytosterol analog) on day 1. Measure plasma isotope enrichment over 72h via GC-MS to calculate fractional cholesterol absorption and LDL turnover rate. Administer 2g/day phytosterols for 4 weeks, then repeat. Compare pre- and post-intervention absorption efficiency and LDL clearance kinetics. Control for bile acid recycling and gut microbiota via fecal metagenomics.
Direct effect of phytosterols on LDL receptor expression in human hepatocytes
Obtain liver tissue from patients undergoing partial hepatectomy (n=15). Expose hepatocyte cultures to physiologic concentrations of sitosterol (10μM) vs. control. Measure LDLR mRNA (qPCR), LDLR protein (Western blot), and LDL uptake (fluorescent LDL assay) over 24h. Include genetic controls (e.g., carriers of LDLR mutations). Confirm specificity by blocking NPC1L1 transporter to isolate phytosterol effect.
Consistency of LDL reduction and mechanistic link across diverse populations
Aggregate individual-level data from 20+ published RCTs (n>2000 total) testing phytosterol intake (1.5–3g/day) for 3–12 weeks. Analyze LDL-C change as primary outcome. Secondary: correlate LDL-C reduction with baseline cholesterol absorption (via campesterol/cholesterol ratio) and genetic markers (ABCG5/G8 SNPs). Use multivariate regression to isolate phytosterol effect from confounders (diet, BMI, statins).
Causal necessity of LDL receptors in phytosterol-mediated LDL lowering
Use LDLR-knockout mice and wild-type controls (n=10/group). Feed both diets supplemented with 0.5% sitosterol for 8 weeks. Measure plasma LDL-C, hepatic LDLR expression (if present), and fecal sterol excretion. If phytosterols fail to lower LDL-C in LDLR-knockouts but succeed in wild-types, this confirms LDLR upregulation is necessary for the effect. Include cholesterol absorption assays via dual-isotope method.